Global Travel Vaccines Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Forecasted Market Size of the Travel Vaccines Market by 2030?
The travel vaccines market size has grown strongly in recent years. It will grow from $5.09 billion in 2025 to $5.56 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to limited access to vaccines in emerging markets, low public awareness of travel-related diseases, reliance on traditional vaccination centers, regulatory approvals for mono vaccines, slow adoption of online booking platforms.

The travel vaccines market size is expected to see rapid growth in the next few years. It will grow to $8.16 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing global travel and mobility, advancements in biotechnology for combination vaccines, growth of digital health and telemedicine services, rising awareness of preventive healthcare, expansion of international travel immunization programs. Major trends in the forecast period include rise in international tourism and business travel, increasing awareness of preventive healthcare for travelers, expansion of online travel health services and booking platforms, development of combination and multivalent travel vaccines, growth in public-private partnerships for global immunization programs.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

What Are the Key Market Drivers and Opportunities in the Travel Vaccines Market?
The increase in travel and tourism is expected to propel the growth of the travel vaccine market going forward. Travel and tourism refer to the movement of people or things, including vehicles like trains, boats, airplanes, and other conveyances, between various remote geographic areas. Travel vaccines are helpful for tourists and travelers by keeping them safe and healthy while they are traveling abroad. For instance, in May 2025, according to UN Tourism, a Spain-based specialized agency responsible for the promotion of responsible, sustainable, and universally accessible tourism, in the first three months of 2025, over 300 million tourists traveled internationally, about 14 million more than during the same period in 2024, which marks a 5% year-on-year increase. Therefore, the increase in travel and tourism is driving the growth of the travel vaccine market.

How Is the Travel Vaccines Market Mapped Across Its Segment Categories?
The travel vaccines market covered in this report is segmented –

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel

What Are the Most Prominent Trends Impacting the Travel Vaccines Market?
Major companies operating in the travel vaccine market are developing innovative vaccines to provide active immunization to prevent Hepatitis A common concern for travelers. A travel vaccine is a vaccine specifically designed to protect individuals from infectious diseases that are prevalent in certain regions or countries, often recommended for travelers visiting those areas. For instance, in January 2024, Indian Immunologicals Ltd. (IIL), an India-based biotechnology company, launched Havisure, India’s first indigenously developed Hepatitis A vaccine. Havisure is anticipated to be instrumental in providing protection against the Hepatitis A virus, which mainly impacts the liver. This vaccine is effective in preventing the disease and is advised for children as part of routine immunization. Additionally, it is recommended for individuals at risk of exposure or those traveling to areas with high rates of hepatitis A.

What Are the Top Companies to Watch in the Travel Vaccines Market?
Major companies operating in the travel vaccines market are Pfizer Inc, Johnson and Johnson, Merck & Co. Inc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Bharat Biotech International Limited, Bio Farma, Novavax Inc, Emergent BioSolutions UK, Biological E. Limited, Vabiotech, Cadila Healthcare Limited, Zydus Lifesciences Ltd, Cipla Inc, Haffkine Biopharmaceutical Corporation Ltd

Get the full travel vaccines market report here:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

Which Regions Are Forecasted to Experience the Fastest Growth in the Travel Vaccines Market?
North America was the largest region in the travel vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn